HighTower Advisors
PAHC icon

HighTower Advisors’s Phibro Animal Health PAHC Stock Holding History

HighTower Advisors’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,420
Closed -$521K – 3965
2026
Q1 		$521K Buy
+9,420
New +$448K ﹤0.01% 2681
2023
Q3 		– Sell
-12,249
Closed -$167K – 3703
2023
Q2 		$167K Buy
12,249
+176
+1% +$2.52K ﹤0.01% 2935
2023
Q1 		$188K Buy
+12,073
New +$184K ﹤0.01% 2781

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

HighTower Advisors's PAHC Position: Q2 2026 in Review

HighTower Advisors sold out of Phibro Animal Health (PAHC) in Q2 2026, closing a stake of 9,420 shares — an estimated $521K sold.

HighTower Advisors first reported a position in PAHC in Q1 2023 and held it in 3 quarters. The position peaked at $521K in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • HighTower Advisors reported no remaining Phibro Animal Health position as of Q2 2026 after selling out during the quarter.
  • HighTower Advisors sold 9,420 Phibro Animal Health shares in Q2 2026, an estimated $521K.
  • HighTower Advisors first reported a position in Phibro Animal Health in Q1 2023 and held it in 3 quarters.
  • HighTower Advisors's Phibro Animal Health position peaked at $521K in Q1 2026.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.